Can-Fite BioPharma CANF
NYSE CANF
$2.18 -0.06 (-2.68%)
At close: Oct 2, 2026 · 4:00 PM EDT

Can-Fite BioPharma (CANF) Price to Earnings (2016 - 2017)

Updated

Can-Fite BioPharma's (CANF) Price to Earnings was 452.27 for Q3 2017, up 7.2% from the prior quarter.

Analysis

Can-Fite BioPharma (CANF) Price to Earnings (2016 - 2017) Analysis & Trends

For FY2016, Price to Earnings at Can-Fite BioPharma was 588.96.

  • Five-year quarterly Price to Earnings spans a low of 421.94 in Q2 2017 and a high of 792.44 in Q1 2017.
  • Per Business Quant data, the three quarters before Q3 2017 came in at 421.94 (Q2 2017), 792.44 (Q1 2017) and 598.66 (Q4 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Can-Fite BioPharma 1.79 Mn -17.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 452.27
Jun 30, 2017 421.94
Mar 31, 2017 792.44
Dec 31, 2016 598.66
API Access

Can-Fite BioPharma Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CANF&period=max&api_key=YOUR_API_KEY